Stay updated on Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T16:27:57.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting updates. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T10:41:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page now features a Show glossary option and green/red color-coded highlights to indicate additions and deletions. It also displays the Revision: v3.4.0 release note while substantive study data remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T06:36:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Active, not recruiting as of 2026-01-07 is now shown, with new sections for Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Study Description, Study Status, and Study Identification. The previous version listed Not yet recruiting and the last known status was Liu Yunjiang, Hebei Medical University Fourth Hospital.
    Difference
    2%
    Check dated 2026-01-14T02:23:05.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer.
    Difference
    0.2%
    Check dated 2025-12-23T22:05:48.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The change is a minor software version update from v3.2.0 to v3.3.2; no study data, history entries, or page content are altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:38:06.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.